BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10851498)

  • 1. Necessity of biotherapeutic treatments inducing TH1 cell functions in colorectal cancer.
    Contasta I; Pellegrini P; Berghella AM; Del Beato T; Canossi A; Di Rocco M; Adorno D; Casciani CU
    Cancer Biother Radiopharm; 1996 Dec; 11(6):373-83. PubMed ID: 10851498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological directives for biotherapy improvement in the treatment of colorectal cancer.
    Pellegrini P; Berghella AM; Del Beato T; Adorno D; Casciani CU
    Cancer Biother Radiopharm; 1996 Apr; 11(2):113-8. PubMed ID: 10851527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the soluble CD30 serum level in colorectal cancer: a possible marker for a patient subset which could benefit from IL-2 biotherapy.
    Dle Beato T; Berghella AM; Pellegrini P; Domenico A; Casciani CU
    Cancer Biother Radiopharm; 1997 Oct; 12(5):297-304. PubMed ID: 10851480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and back.
    Berghella AM; Pellegrini P; Del Beato T; Marini M; Tomei E; Adorno D; Casciani CU
    Cancer Immunol Immunother; 1998 Jan; 45(5):241-9. PubMed ID: 9439647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of immunological evaluation in colorectal cancer.
    Berghella AM; Pellegrini P; Del Beato T; Maccarone D; Adorno D; Casciani CU
    Cancer Biother Radiopharm; 1996 Dec; 11(6):355-61. PubMed ID: 10851496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression.
    Pellegrini P; Berghella AM; Del Beato T; Cicia S; Adorno D; Casciani CU
    Cancer Immunol Immunother; 1996 Jan; 42(1):1-8. PubMed ID: 8625361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sCEA molecule suppressive role in NK and TH1 cell functions in colorectal cancer.
    Pellegrini P; Berghella AM; Del Beato T; Maccarone D; Cencioni S; Adorno D; Casciani CU
    Cancer Biother Radiopharm; 1997 Aug; 12(4):257-64. PubMed ID: 10851473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
    Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M
    Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer.
    Berghella AM; Pellegrini P; Del Beato T; Adorno D; Casciani CU
    Cancer Biother Radiopharm; 1997 Aug; 12(4):265-72. PubMed ID: 10851474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of colorectal cancer upon host peripheral immune cell function.
    Evans CF; Galustian C; Bodman-Smith M; Dalgleish AG; Kumar D
    Colorectal Dis; 2010 Jun; 12(6):561-9. PubMed ID: 19250260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological implications of alterations in the c-Ki-ras and p53 genes in the stepwise progression of colorectal cancer: indications for the improvement of prognosis, biotherapy treatment and tumor biology understanding.
    Contasta I; Pellegrini P; Berghella AM; Del Beato T ; Canossi A; Maccarone D; Papola F; Adorno D; Casciani CU
    Cancer Biother Radiopharm; 1997 Dec; 12(6):385-93. PubMed ID: 10851492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions.
    Contasta I; Berghella AM; Pellegrini P; Adorno D
    Cancer Biother Radiopharm; 2003 Aug; 18(4):549-57. PubMed ID: 14503949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
    Pellegrini P; Berghella AM; Contasta I; Adorno D
    Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 T-helper cell cytokine phenotypes and antibody response following tetanus toxoid booster immunization.
    Livingston KA; Jiang X; Stephensen CB
    J Immunol Methods; 2013 Apr; 390(1-2):18-29. PubMed ID: 23318779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro cytokine responses of peripheral blood mononuclear cells from healthy dogs to distemper virus, Malassezia and Toxocara.
    Valli JL; Williamson A; Sharif S; Rice J; Shewen PE
    Vet Immunol Immunopathol; 2010 Apr; 134(3-4):218-29. PubMed ID: 19880197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of type 1 and type 2 T cells in synovial fluid and peripheral blood of patients with rheumatoid arthritis.
    Kusaba M; Honda J; Fukuda T; Oizumi K
    J Rheumatol; 1998 Aug; 25(8):1466-71. PubMed ID: 9712085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis.
    Capobianchi MR
    J Biol Regul Homeost Agents; 1996; 10(4):83-91. PubMed ID: 9604776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.
    Bellinghausen I; Metz G; Enk AH; Christmann S; Knop J; Saloga J
    Eur J Immunol; 1997 May; 27(5):1131-9. PubMed ID: 9174602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High serum levels of soluble IL-2 receptor, cytokines, and C reactive protein correlate with impairment of T cell response in patients with advanced epithelial ovarian cancer.
    Macciò A; Lai P; Santona MC; Pagliara L; Melis GB; Mantovani G
    Gynecol Oncol; 1998 Jun; 69(3):248-52. PubMed ID: 9648596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.